EUVIMEDEUVIMED entdecken
Crossref

Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance

Jiping Sun, Youqin Zhang, Qingbing Zhang, Lin Hu, Linfeng Zhao, Hongdong Wang, Yue Yuan, Hongshen Niu, Dongdi Wang, Huasheng Zhang, Jianyue Liu, Xujiao Feng und 9 weitere

Immunity · 2024-06 · 57 (6) · 1289-1305.e9

DOI: 10.1016/j.immuni.2024.04.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024-06. Verfasst von Jiping Sun und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 2…. Hauptthemen laut MEDLINE: Insulin Resistance, Programmed Cell Death 1 Receptor, Protein Serine-Threonine Kinases, Mitochondria. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, School of Medicine, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose tissue group 2 innate lymphoid cells (ILC2s) help maintain metabolic homeostasis by sustaining type 2 immunity and promoting adipose beiging. Although impairment of the ILC2 compartment contributes to obesity-associated insulin resistance, the underlying mechanisms have not been elucidated. Here, we found that ILC2s in obese mice and humans exhibited impaired liver kinase B1 (LKB1) activation. Genetic ablation of LKB1 disrupted ILC2 mitochondrial metabolism and suppressed ILC2 responses, resulting in exacerbated insulin resistance. Mechanistically, LKB1 deficiency induced aberrant PD-1 expression through activation of NFAT, which in turn enhanced mitophagy by suppressing Bcl-xL expression. Blockade of PD-1 restored the normal functions of ILC2s and reversed obesity-induced insulin resistance in mice. Collectively, these data present the LKB1-PD-1 axis as a promising therapeutic target for the treatment of metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceProgrammed Cell Death 1 ReceptorProtein Serine-Threonine KinasesMitochondriaHomeostasisAdipose TissueObesityLymphocytesAnimalsMiceHumansAMP-Activated Protein KinasesMice, Inbred C57BLMice, KnockoutImmunity, InnateMaleMitophagyAMP-Activated Protein Kinase Kinases

Stichwörter der Autor:innen

PD-1group 2 innate lymphoid cellsinsulin resistanceliver kinase B1mitophagy

Substanzen

Programmed Cell Death 1 ReceptorProtein Serine-Threonine KinasesStk11 protein, mouseAMP-Activated Protein KinasesSTK11 protein, humanPdcd1 protein, mouseAMP-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • Center for Immune-Related Diseases at Shanghai Institute of Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Department of Immunology and Microbiology, Key Laborator…
  • Department of Endocrinology, Drum Tower Hospital affiliated with Nanjing University Medical School, Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing 210008, China.
  • Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Un…
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
  • Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang 310024, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • School of Medicine, Shanghai Jiao Tong University
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Sun, J., Zhang, Y., Zhang, Q., Hu, L., Zhao, L., Wang, H., Yuan, Y., Niu, H., Wang, D., Zhang, H., Liu, J., Feng, X., Su, X., Qiu, J., Sun, J., Xu, H., Zhang, C., Wang, K., Bi, Y., …, & Shen, L. (2024). Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance. Immunity, 57(6), 1289-1305.e9. https://doi.org/10.1016/j.immuni.2024.04.024

Vancouver

Sun J, Zhang Y, Zhang Q, Hu L, Zhao L, Wang H, et al. Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance. Immunity. 2024;57(6):1289-1305.e9. doi:10.1016/j.immuni.2024.04.024

BibTeX
@article{Sun2024,
  author = {Sun, Jiping and Zhang, Youqin and Zhang, Qingbing and Hu, Lin and Zhao, Linfeng and Wang, Hongdong and Yuan, Yue and Niu, Hongshen and Wang, Dongdi and Zhang, Huasheng and Liu, Jianyue and Feng, Xujiao and Su, Xiaohui and Qiu, Ju and Sun, Jing and Xu, Heping and Zhang, Catherine and Wang, Kathleen and Bi, Yan and Engleman, Edgar G and Shen, Lei},
  title = {Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance},
  journal = {Immunity},
  year = {2024},
  volume = {57},
  number = {6},
  pages = {1289--1305.e9},
  doi = {10.1016/j.immuni.2024.04.024}
}
Kostenlos starten →